Skip to main content
. 2022 Mar 3;10(3):391. doi: 10.3390/vaccines10030391

Figure 1.

Figure 1

SARS-CoV-2-specific binding antibody responses and neutralizing activities. Immune response of individuals with SARS-CoV-2 breakthrough infection (CV + CV + Infection) was compared to those with fully vaccinated CoronaVac vaccines without infection (CV + CV) and those who received AZD1222 as third booster (CV + CV + AZ). Serum (a) anti-RBD Ig activity, (b) anti-RBD IgG-binding antibody units. The results are shown as Geometric mean titres with 95% CIs. The cut-off value is indicated as dotted lines. Statistics were calculated using one-way ANOVA with Bonferroni correction. *** p < 0.001.